51
10.04.2011 1 ICOPIC 2011 PAT solutions for PAT solutions for pharmaceutical industry pharmaceutical industry Semenov Institute of Chemical Physics Russian chemometric society Alexey L. Pomerantsev

Alexey L. Pomerantsev

  • Upload
    others

  • View
    8

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Alexey L. Pomerantsev

10.04.2011 1ICOPIC 2011

PAT solutions for PAT solutions for pharmaceutical industrypharmaceutical industry

Semenov Institute of

Chemical Physics Russianchemometric

society

Alexey L. Pomerantsev

Page 2: Alexey L. Pomerantsev

10.04.2011 2ICOPIC 2011

Content

• Introduction

• Case study 1: Incoming Inspection

• Case study 2: Process Control

• Case study 3: Outcoming Inspection

Page 3: Alexey L. Pomerantsev

10.04.2011 3ICOPIC 2011

Process Analytical TechnologyProcess Analytical Technology

PAT is a system for designing, analyzing, and controlling manufacturing through timely measurements (i.e., during processing) of critical quality and performance attributes of raw and in-process materials and processes, with the goal of ensuring final product quality.

Guidance for Industry PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality AssurancePharmaceutical CGMPs, September 2004

PAT is a system for designing, analyzing, and controlling manufacturing through timely measurements (i.e., during processing) of critical quality and performance attributes of raw and in-process materials and processes, with the goal of ensuring final product quality.

Guidance for Industry PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality AssurancePharmaceutical CGMPs, September 2004

Page 4: Alexey L. Pomerantsev

10.04.2011 4ICOPIC 2011

PAT InstrumentsPAT Instruments

Page 5: Alexey L. Pomerantsev

10.04.2011 5ICOPIC 2011

Near Infra Red spectroscopyNear Infra Red spectroscopy

1200 1400 1600 1800 2000-2

-1

0

1

2

3

Wavelength (nm)

Abso

rban

ce

Page 6: Alexey L. Pomerantsev

10.04.2011 6ICOPIC 2011

Generic PAT SolutionsGeneric PAT Solutions

Incoming inspection

Outcominginspection

Processcontrol

Substance Process Product

Page 7: Alexey L. Pomerantsev

10.04.2011 7ICOPIC 2011 7

Case study 1: Incoming InspectionCase study 1: Incoming Inspection

To design a quick and

simple routine procedure for

recognition the perfect raw

pharmaceutical substances

directly in a warehouse

Page 8: Alexey L. Pomerantsev

10.04.2011 8ICOPIC 2011

The goalThe goal

Material: Taurine, a non-essential sulfur-containing amino acid

Data: NIR spectra measured in 4100 -10000 cm–1 region, resolution 2 cm–1

Substance: in the closed PE bags, 82 drums measured 3 times, totally: 246 spectra

Page 9: Alexey L. Pomerantsev

10.04.2011 9ICOPIC 2011

SpectraSpectra

cm–1

absorbance

Page 10: Alexey L. Pomerantsev

10.04.2011 10ICOPIC 2011

Explorative analysisExplorative analysis

-3

0

3

-5 0 5 10 15 20

PC1

PC2

-3

0

3

-5 0 5 10 15 20

PC1

PC2

The problem:

60 points of 246 are outliers.

Are they fakes?

Page 11: Alexey L. Pomerantsev

10.04.2011 11ICOPIC 2011

0.0

0.5

1.0

1.5

2.0

4000 5000 6000 7000 8000 9000, cm–1

absorbance

Substance

PE

0.0

0.5

1.0

1.5

2.0

4000 5000 6000 7000 8000 9000, cm–1

absorbance

A1

A2

A1 – low PE influence

A2 – high PE influence

Reason of failureReason of failure

Page 12: Alexey L. Pomerantsev

10.04.2011 12ICOPIC 2011

Probe position effectProbe position effect

Page 13: Alexey L. Pomerantsev

10.04.2011 13ICOPIC 2011

Model 1

Dots are the training samples (Group 1)Squares are the test samples (Group 2)

Two PCA modelsTwo PCA models

-2

2

6

10

-6 -2 2

PC1

PC2

-3

0

3

-10 0 10

PC1

PC2

Model 2

Squares are the training samples (Group 1)Dots are the test samples (Group 2)

Page 14: Alexey L. Pomerantsev

10.04.2011 14ICOPIC 2011

Routine testing procedureRoutine testing procedure

Spectrumacquisition

Good Sample

Yes Test against Model 1

YesBadsample

No Test against Model 2

No

Page 15: Alexey L. Pomerantsev

10.04.2011 15ICOPIC 2011

Case study conclusionsCase study conclusions

• Probing robust method

• Qualitative trihotomy analysis: yes / no / try again

• 100 % inspection (≤ 3 trials)

• Probing robust method

• Qualitative trihotomy analysis: yes / no / try again

• 100 % inspection (≤ 3 trials)

Page 16: Alexey L. Pomerantsev

10.04.2011 16ICOPIC 2011

DetailsDetails

Page 17: Alexey L. Pomerantsev

10.04.2011 17ICOPIC 2011 17

Case study 2: Process ControlCase study 2: Process Control

To predict the drug release profiles during a running pellet coating process from the in-line near infrared (NIR) measurements

Page 18: Alexey L. Pomerantsev

10.04.2011 18ICOPIC 2011

Objects: PelletsObjects: PelletsSugar +API

Coating: Acryl EZE

Page 19: Alexey L. Pomerantsev

10.04.2011 19ICOPIC 2011

Fluid bed coatingFluid bed coating

Page 20: Alexey L. Pomerantsev

10.04.2011 20ICOPIC 2011

ExperimentExperiment

NIR Spectra Dissolution Profiles

t = 0t = 30t = 42t = 50t = 105

Page 21: Alexey L. Pomerantsev

10.04.2011 21ICOPIC 2011

Our goalOur goal

Prediction

Page 22: Alexey L. Pomerantsev

10.04.2011 22ICOPIC 2011

Data overviewData overview

Samples

1 2 3 4 5 6 7 8 9

B a t c h e s

W1 25 44 62 82 99 117 136 154 171

W2 22 37 52 67 81 98 110 124 142

W3 18 30 41 52 62 73 85 97 114

W4 19 36 52 67 83 98 114 129 137

W5 18 31 42 51 61 70 79 89 105

W6 39 70 98 127 156 188 215 246 260

W7 19 34 48 64 79 95 111 125 140

Y1 21 40 59 77 96 115 133 152 168

Y2 20 30 43 55 67 82 92 105 121

Y3 24 46 70 89 111 133 155 176 191

Y4 26 50 74 98 122 150 171 194 209

Y5 18 31 42 52 63 73 83 94 110

Y6 19 34 49 64 79 94 109 124 140

Process time, min

Page 23: Alexey L. Pomerantsev

10.04.2011 23ICOPIC 2011

Conventional approachConventional approach

Spectra Dissolution time (min)Wavelengths 0 15 30 45 60 90 120 180 240

Samples

1

2

3

4

5

6

7

8

9

PLS2

Page 24: Alexey L. Pomerantsev

10.04.2011 24ICOPIC 2011

PLS2 resultsPLS2 results

Page 25: Alexey L. Pomerantsev

10.04.2011 25ICOPIC 2011

Kinetic approachKinetic approach

k1 k2 ... kp

Samples

1 3.56 0.10 ... 0.33

2 4.03 0.09 ... 0.66

3 4.99 0.10 ... 0.98

4 6.13 0.15 ... 1.28

5 6.84 0.20 ... 1.62

6 7.81 0.25 ... 1.93

7 8.66 0.30 ... 2.23

8 9.49 0.33 ... 2.54

9 9.82 0.35 ... 2.54

Features extraction

Page 26: Alexey L. Pomerantsev

10.04.2011 26ICOPIC 2011

AutocatalysisAutocatalysis

[ ][ ]tkmkm

tkmkkmt)(exp1)(exp100),,(

++−+

[ ] [ ][ ]

[ ]B

0)0(B

100BA

BA

2BBA

=

=+

⎯→⎯

⎯→⎯+

k

m

m

k

Page 27: Alexey L. Pomerantsev

10.04.2011 27ICOPIC 2011

Fitter softwareFitter software

Page 28: Alexey L. Pomerantsev

10.04.2011 28ICOPIC 2011

Parameter Parameter mm is common within a batchis common within a batch

Page 29: Alexey L. Pomerantsev

10.04.2011 29ICOPIC 2011

Parameter Parameter mm and the layer gradeand the layer grade

Page 30: Alexey L. Pomerantsev

10.04.2011 30ICOPIC 2011

Parameter Parameter k k and the layer thickness and the layer thickness

Layer thickness

Page 31: Alexey L. Pomerantsev

10.04.2011 31ICOPIC 2011

Intermediate conclusionsIntermediate conclusions

parameter k depends on the layer thicknessparameter k depends on the layer thickness

parameter mreflects the material gradeparameter mreflects the material grade

parameter k keeps track of batch variationsparameter k keeps track of batch variations

Page 32: Alexey L. Pomerantsev

10.04.2011 32ICOPIC 2011

Prediction of Prediction of kk: NLR : NLR –– NIR (White subset)NIR (White subset)

Page 33: Alexey L. Pomerantsev

10.04.2011 33ICOPIC 2011

Prediction of Prediction of kk: NLR : NLR –– NIR (Yellow subset)NIR (Yellow subset)

Page 34: Alexey L. Pomerantsev

10.04.2011 34ICOPIC 2011

Prediction techniquePrediction technique

NLR

m :common for the grade

k11 , .... , k19 : for batch 1

k21 , .... , k29 : for batch 2

k31 , .... , k39 : for batch 3

k41 , .... , k49 : for batch 4

PLS

PLSk

Page 35: Alexey L. Pomerantsev

10.04.2011 35ICOPIC 2011

Test set validation: W2 and Y5 predictionTest set validation: W2 and Y5 prediction

Page 36: Alexey L. Pomerantsev

10.04.2011 36ICOPIC 2011

ConclusionsConclusions

• PAT solution for the in-line release profile prediction

• novel “curve to curve” calibration approach via NLR

• autocatalytic model for the drug release

• PAT solution for the in-line release profile prediction

• novel “curve to curve” calibration approach via NLR

• autocatalytic model for the drug release

Page 37: Alexey L. Pomerantsev

10.04.2011 37ICOPIC 2011

DetailsDetails

Page 38: Alexey L. Pomerantsev

10.04.2011 38ICOPIC 2011 38

Case study 3: Case study 3: OutcomingOutcoming InspectionInspection

To design a quick and simple

routine procedure for the in-line

inspection of the finished

pharmaceutical products

Page 39: Alexey L. Pomerantsev

10.04.2011 39ICOPIC 2011

Two years agoTwo years ago: : AprilApril 20092009

Mildronate

Soft remedy for treatment of the heart and blood vessel diseases

Listenon

Strong drug applied for the muscle relaxation in anesthesia and for intensive care

Page 40: Alexey L. Pomerantsev

10.04.2011 40ICOPIC 2011

4% aqueous solution of 4% aqueous solution of dexamethasonedexamethasone((glucocorticosteroidglucocorticosteroid remedy)remedy)

Genuine objects

batch G1: 15 ampoules

batch G2 : 15 ampoules

Counterfeit objects

batch F2: 15 ampoules

Page 41: Alexey L. Pomerantsev

10.04.2011 41ICOPIC 2011

NIR layoutNIR layout

Bomem 160 FT NIR

spectral range 5500 - 10000 cm–1

resolution 8 cm–1

8 mm vial holder

T= 30ºC

Page 42: Alexey L. Pomerantsev

10.04.2011 42ICOPIC 2011

NIR spectraNIR spectra

30 genuine

15 fakes

Page 43: Alexey L. Pomerantsev

10.04.2011 43ICOPIC 2011

PCA analysisPCA analysis

Page 44: Alexey L. Pomerantsev

10.04.2011 44ICOPIC 2011

SIMCA classificationSIMCA classification

Training set is G1 Training set is G1+G2

Page 45: Alexey L. Pomerantsev

10.04.2011 45ICOPIC 2011

Wet chemistry analysisWet chemistry analysis

GC-MS

HPLC-DAD-MS

CE-UV

Page 46: Alexey L. Pomerantsev

10.04.2011 46ICOPIC 2011

HPLCHPLC-- DAD Chromatograms DAD Chromatograms λλ=254 nm =254 nm

Page 47: Alexey L. Pomerantsev

10.04.2011 47ICOPIC 2011

Peak areas of the common impuritiesPeak areas of the common impurities

genuine sample G1 is used as the reference (HPLC-DAD-UV at λ=254 nm)

Page 48: Alexey L. Pomerantsev

10.04.2011 48ICOPIC 2011

Case study conclusionsCase study conclusions

• We do not check composition, e.g. the API concentration

• Qualitative analysis: yes / no

• 100 % inspection

• We do not check composition, e.g. the API concentration

• Qualitative analysis: yes / no

• 100 % inspection

Page 49: Alexey L. Pomerantsev

10.04.2011 49ICOPIC 2011

DetailsDetails

Page 50: Alexey L. Pomerantsev

10.04.2011 50ICOPIC 2011

CollaboratorsCollaborators

OxanaRodionovaICP RASRussia

LarsHoumøllerArla FoodsDenmark

AndreyBogomolovJ&M Germany

OlegShpigunMSURussia

Page 51: Alexey L. Pomerantsev

10.04.2011 51ICOPIC 2011

ThanksThanks!!